Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000040579Phase 4Not yet recruiting
Phase 4, randomised, open-label trial in hypertension (HTN) comparing Propofol arm with Remimazolam arm (2 arms). Primary endpoints: Blood pressure, Heart rate and 3 more. Planned start Nov 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000040579.